share_log

Genertec Universal Medical Group Company Limited's (HKG:2666) Last Week's 5.3% Decline Must Have Disappointed Private Companies Who Have a Significant Stake

Genertec Universal Medical Group Company Limited's (HKG:2666) Last Week's 5.3% Decline Must Have Disappointed Private Companies Who Have a Significant Stake

醫療通用集團有限公司(HKG:2666)上週股價下跌了5.3%,這一定讓重要股東私營企業感到失望。
Simply Wall St ·  06/14 19:44

Key Insights

主要見解

  • Significant control over Genertec Universal Medical Group by private companies implies that the general public has more power to influence management and governance-related decisions
  • A total of 3 investors have a majority stake in the company with 50% ownership
  • Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
  • 私人公司對百利生醫藥集團的重要控制意味着普通公衆擁有更大的權力來影響管理和治理相關決策。
  • 一共有3個投資者持有該公司的絕大多數股份,佔有50%的股權。
  • 所有權研究和分析師預測數據有助於更好地了解股票市場的機會。

A look at the shareholders of Genertec Universal Medical Group Company Limited (HKG:2666) can tell us which group is most powerful. With 50% stake, private companies possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

查看百利生醫藥集團有哪些股東可以知道哪個集團最有權勢。私人公司擁有該公司的最大股份50%。換句話說,該集團將從其進入公司的投資中獲得最多(或損失最多)的盈利。

And last week, private companies endured the biggest losses as the stock fell by 5.3%.

上週,私人公司承受了最大的損失,因爲該股票下跌了5.3%。

Let's delve deeper into each type of owner of Genertec Universal Medical Group, beginning with the chart below.

讓我們深入了解百利生醫藥集團每種所有者,從下面的圖表開始。

ownership-breakdown
SEHK:2666 Ownership Breakdown June 14th 2024
SEHK:2666 2024年6月14日的所有權分佈情況

What Does The Institutional Ownership Tell Us About Genertec Universal Medical Group?

機構的持股情況對百利生醫藥集團意味着什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

Genertec Universal Medical Group already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Genertec Universal Medical Group, (below). Of course, keep in mind that there are other factors to consider, too.

百利生醫藥集團已經有機構在股份登記簿上。事實上,他們在公司擁有可觀的股權。這可能表示該公司在投資社區中享有一定的信譽度。然而,最好還是謹慎地依賴機構投資者所伴隨的假定確認。他們也會犯錯誤。如果兩個大型機構投資者同時嘗試拋售某個股票,那麼很常見看到股價大幅下跌。因此,值得檢查百利生醫藥集團的過去收益軌跡(如下)。當然,也要記住,還有其他因素需要考慮。

earnings-and-revenue-growth
SEHK:2666 Earnings and Revenue Growth June 14th 2024
SEHK:2666 2024年6月14日的營收和收入增長情況

Genertec Universal Medical Group is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is China General Technology (Group) Holding Co.,Ltd. with 39% of shares outstanding. In comparison, the second and third largest shareholders hold about 7.9% and 3.0% of the stock.

百利生醫藥集團不屬於對沖基金。從數據上看,我們可以看到中國通號控股有限公司持有39%的流通股。相比之下,第二和第三大股東持有該股票的約7.9%和3.0%。

A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 50% stake.

股東登記表的更詳細研究顯示,前3大股東通過其50%的股份擁有相當大的公司所有權。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

儘管有道理去研究一家公司的機構所有權數據,但了解分析師的觀點也很有道理,以便知道市場的風向。由於相當多的分析師涵蓋了該股票,因此您可以很容易地研究預測的增長。

Insider Ownership Of Genertec Universal Medical Group

百利生醫藥集團的內部持股情況

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間是不同的。我們的數據反映了個別內部人員,至少捕捉到了董事會成員。公司管理業務,但首席執行官即使是董事會成員也必須向董事會負責。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。

Our data suggests that insiders own under 1% of Genertec Universal Medical Group Company Limited in their own names. However, it's possible that insiders might have an indirect interest through a more complex structure. Keep in mind that it's a big company, and the insiders own HK$33m worth of shares. The absolute value might be more important than the proportional share. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.

我們的數據表明,認股權證不到百利生醫藥集團股份有限公司的股份總額的1%。但是,內部人員可能通過更復雜的結構間接擁有利益。請記住,這是一家大公司,內部人員擁有價值3300萬元的股份。絕對價值可能比比例份額更重要。看到董事會成員擁有股份是好的,但最好檢查這些內部人員是否一直在買入。

General Public Ownership

一般大衆所有權

The general public-- including retail investors -- own 43% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

包括散戶在內的普通公衆擁有該公司43%的股份,因此不能輕易忽視他們。儘管所有權規模相當大,但如果決定與其他大股東不一致,這可能還不足以改變公司政策。

Private Company Ownership

私有公司的所有權

It seems that Private Companies own 50%, of the Genertec Universal Medical Group stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

似乎私人公司擁有百利生醫藥集團股票的50%。僅從這個事實本身很難得出任何結論,因此值得調查誰擁有那些私人公司。有時候內部人員或其他相關方通過單獨的私人公司在公衆公司的股份上擁有利益。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 2 warning signs for Genertec Universal Medical Group (1 makes us a bit uncomfortable!) that you should be aware of before investing here.

當考慮擁有一家公司的不同群體時, 還應該考慮其他更重要的因素。例如,我們發現了Genertec Universal Medical Group的2個警告信號(其中1個讓我們有點不舒服!),在這裏進行投資之前應該注意。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果您想發現分析師對未來增長的預測,請不要錯過這份有關分析師預測的免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,也可以發送電子郵件至editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論